Drugs / Stryphnodendron Adstringens
last change Dec 2023 re-read 3 minutes ago

Stryphnodendron Adstringens

Investigated by
Biolab Sanus Farmaceutica · Medcin Instituto da Pele

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06085898 Nov → Dec 2023 bacterial vaginosis Biolab Sanus Farmaceutica Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Stryphnodendron Adstringens ClinicalTrials.gov intervention name — accepted as the source's own label NCT06085898 ↗